ng28ÄϹ¬Ðû²¼£¬¡¶Ê±´ú¡·ÔÓÖ¾ÆÀÑ¡°¢¶û´Äº£Ä¬²¡£¨AD£©ÖÎÁÆÒ©Îï LEQEMBI? £¨lecanemab-irmb£©Îª “2023 ÄêÒ½ÁƱ£½¡Àà×î¼Ñ·¢Ã÷´´Á¢”Ö®Ò»¡£
¡¶Ê±´ú¡·Äê¶È “×î¼Ñ·¢Ã÷´´Á¢”°ñµ¥ÁгöÁË “200 Ïî¸Ä±äÉú»îµÄÌØÊâÁ¢Ò씡£¡¶Ê±´ú¡·ÏòÈ«Çò¸÷µØµÄ±à¼ºÍ¼ÇÕßÕ÷¼¯ÌáÃû£¬²¢Í¨¹ý¹ûÕæÔÚÏßÉêÇë³ÌÐòÒÔ»ã±àÕâ·Ý°ñµ¥£¬²¢Ìرð¹Ø×¢È˹¤ÖÇÄÜ¡¢ÂÌÉ«ÄÜÔ´ºÍ¿ÉÁ¬ÐøÉú³¤µÈÁìÓòµÄÉú³¤Çé¿ö¡£ÁíÍ⣬¡¶Ê±´ú¡·Æ¾¾ÝһϵÁÐÒªº¦ÒòËØ£¬°üÀ¨¶À´´ÐÔ¡¢Ð§ÂÊ¡¢ÐÛÐĺÍÓ°ÏìÁ¦£¬¶Ôÿ¸öºòÑ¡ÏîÄ¿½øÐÐÆÀ¹À¡£(ÓûÁ˽â¸ü¶àÐÅÏ¢£¬Çë»á¼û£ºhttp://www.time.com/best-inventions-2023£©¡£
LEQEMBI ÊǵÚÒ»ÖÖÒ²ÊÇΨһһÖÖÔÚÈÕ±¾ºÍÃÀ¹ú»ñµÃÅú×¼µÄÕë¶ÔADµÄDZÔÚ²¡ÀíѧµÄÖÎÁÆÒªÁ죬Ñо¿Ö¤Ã÷Æä¿ÉÒÔ½µµÍ¼²²¡½øÕ¹Ëٶȣ¬¼õ»ºÈÏÖªºÍ¹¦Ð§Ë¥ÍË¡£
ADÊÇÒ»ÖÖÁ¬Ðø½øÕ¹µÄÖÂÃü¼²²¡£¬Ò²ÊÇÒ»¸öÈ«ÇòÐÔµÄÒ½ÁƱ£½¡ÎÊÌ⣬²»µ«¶Ô»¼Õß×Ô¼º£¬²¢ÇÒ¶ÔËûÃǵļÒÊô¡¢»¤Àíͬ°éºÍÉç»á¶¼Óм«´óµÄÓ°Ïì¡£»ùÓÚ “ÌåÌùÈËÀཡ¿µ£¨hhc£©“µÄÆóÒµÀíÄÎÒÃÇͨ¹ý½ü 40 ÄêÀ´ÔÚ³Õ´ôÖ¢ÁìÓòµÄÒ©ÎïÑз¢Ô˶¯£¬Ó뻼Õß¼°Æä¼ÒÊô³¯Ï¦Ïà´¦£¬ÅäºÏÓ¦¶ÔÕâÒ»¼èÄÑÌôÕ½¡£
ÎÒÃǽ«ÏòÓÐÐèÒªµÄÔçÆÚAD»¼Õß¼°Æä¼ÒÊôÌṩ LEQEMBI£¬²¢ÖÂÁ¦ÓÚÁ¬Ðø½â¾öÈ«Çò³Õ´ôÖ¢Ïà¹ØÎÊÌâ¡£
LEQEMBIµÄÈ«Çò¿ª·¢ºÍ¼à¹ÜÌá½»ÓÉng28ÄϹ¬Ö÷µ¼£¬¶ø²úÆ·ÔòÓÉng28ÄϹ¬ºÍ²³½¡ÅäºÏÉÌÒµ»¯ºÍÍƹ㡣ÆäÖУ¬ng28ÄϹ¬ÓµÓÐ×îÖÕ¾ö²ßȨ¡£
Çë²ÎÔÄÍêÕûµÄ´¦·½ÐÅÏ¢£¬°üÀ¨ÃÀ¹úµÄºÚ¿ò¾¯¸æ¡£
MEDIA CONTACTS: Eisai Co., Ltd. Public Relations Department TEL: +81 (0)3-3817-5120